Overview
- Description
The company is pioneering next-generation programmable gene-writing tools—most notably its proprietary FiCAT platform—to revolutionise gene and cell therapies for genetic disorders and treatment-resistant cancers with enhanced precision, efficiency, and safety.
- Website
- Country
- Spain
- Sector
- Health Biotechnology